+ND Capital — Full Portfolio

Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.

BiotechDeep TechSemiconductorsSouth San Francisco, US

William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Emily Leproust(Founder)in

BoardKeith Crandell(Director)Paul Conley(Director)inFred Craves(Director)in

Co-investors3E Bioventures CapitalARCH Venture PartnersAsset Management CompanyBay City CapitalBlack Opal VenturesDentsu Ventures+7 more

Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research.

BiotechDeep TechHealthtech

Donald Ingber(Scientific Founder, Board Member, Scientific Advisory Board Chairman)inDaniel Levner(Co-Founder & CTO)Jim Corbett(CEO, Board Member)Lorna Ewart(Chief Scientific Officer)

Co-investorsNorthpond VenturesAlwyn CapitalFourth RealmStray Dog CapitalOS FundStarlight Ventures

Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation.

BiotechDigital HealthFemTechHealthtechMedical DevicesAarhus, DK

Karin Lykke-Hartmann(Chief Executive Officer & Founder)

PulseSight Therapeutics develops non-viral, plasmid-based gene therapies delivered via a proprietary electro-transfection system into the ciliary muscle to treat severe retinal diseases causing blindness.

BiotechHealthtechMedical Devices

Co-investorsPureos Bioventures

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.

BiotechHealthtechLongevityMedical DevicesLausanne, CH

Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)Peter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)

Co-investorsDolby Family Ventures

AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.

AI & Machine LearningBiotechDeep TechHealthtech

Kris ElveruminTodd Bazemore(Chief Executive Officer)

BoardRodger Novak(Chair)

Co-investorsARCH Venture PartnersForbionVenrockFast Track InitiativeNextech InvestNovalis LifeSciences+2 more

BiotechSouth San Francisco, US

Wendye Robbins(Executive Officer, Director)

BoardLuke Evnin(Director)inCameron Wheeler(Director)Elaine Jones(Director)William Slattery(Director)

Board seatPeter Van Vlasselaer· per SEC Form D · $50M raise · filed Oct 2019

Co-investorsBay City CapitalOUP (Osage University Partners)Pfizer Venture InvestmentsMPM BioImpact

BiotechNew York, US

Masoud Tavazoie(Chief Scientific Officer)David Darst(Chief Operating Officer)Isabel Kurth(Vice President - Research)

BoardShahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)

Board seatPeter Van Vlasselaer· per SEC Form D · $11M raise · filed Feb 2021

Co-investorsSofinnova Partners

ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases.

BiotechHealthtechMedical Devices

Co-investorsArtis Ventures

Co-investorsSanofi VenturesSolasta Ventures

Co-investorsSQN Venture Partners, LLC

Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy.

BiotechLongevityWellness & FitnessLausanne, CH

Co-investorsBold Capital Partners

Arc Therapeutics is a stealth-stage biopharmaceutical company developing medicines for central nervous system (CNS) conditions with high unmet medical needs.

BiotechHealthtech

Co-investorsV-Bio Ventures

Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.

BiotechDeep TechNew Materials

Jason Chin(Professor)

Co-investorsAmadeus Capital PartnersFine Structures VenturesGENERAL INCEPTIONLongeVCOMX VenturesPaladin Capital Group+2 more

Crocus Technology, now part of Allegro MicroSystems, develops XtremeSense TMR (Tunnel Magnetoresistance) magnetic sensing technology used in integrated current and position sensor ICs.

Co-investorsVentechVentech China

Cytoki Pharma is a clinical-stage biotechnology company developing IL-22-based medicines for metabolic diseases such as obesity and type 2 diabetes, and conditions involving epithelial injury like inflammatory bowel disease.

BiotechHealthtechVærløse, DK

Rasmus Jorgensen(Founder)

Co-investorsYsios CapitalSeventure Partners

H55 develops certified electric propulsion systems and energy storage solutions for aviation, enabling aircraft manufacturers to transition to electric flight.

CleantechEnergyHardwareMobility & TransportationSion, CH

André Borschberg(Co-Founder and Executive Chairman)in

Co-investorsACE & Company

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.

AI & Machine LearningBiotechDeep TechHealthtech

Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)Daniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in

Co-investorsBroadview VenturesSofinnova PartnersApollo Health Ventures4see Ventures

BiotechBoulder, US

Michael Graige(Executive Officer)Ron McGrath(Executive Officer)Sri Kosaraju(Executive Officer, Director)Dianna L. DeVore(Executive Officer)

BoardRoger Wyse(Director)inBryan Roberts(Director)

Co-investorsForesite CapitaliGlobe PartnersKorysOak HC/FTOMX VenturesPaladin Capital Group+3 more

Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.

BiotechDeep TechHealthtech

Co-investorsIllumina VenturesLongwall Venture Partners LLPM VenturesOMX VenturesARCH Venture Partners

Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" — sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry — and offers a scale-up platform covering cell factory design through biomanufacturing.

BiotechFoodTechNew MaterialsAugusta, US

Ajikumar Parayil(Executive Officer, Director)inAji Parayil(Co-founder)Greg Stephanopoulos(Co-founder)

BoardJason Whaley(Director)inCarsten Boers(Director)inRichard Goldstein(Director)

Co-investorsCivilization Ventures Management, LlcEnergy Impact PartnersLiebenthal VenturesNelstone VenturesNXT VenturesPrefix Capital+2 more

RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.

BiotechEmeryville, US

Igor Khandros(Executive Officer, Director)

Co-investorsARCH Venture PartnersBluebird Ventures

Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US

Sri Kosuri(Co-founder)inRamsey Homsany(Founder)in

Co-investorsAndreessen Horowitz8VCCarbon SiliconCatalio Capital Management, LPFifty YearsFlucas Ventures+5 more

Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome.

BiotechDigital HealthHealthtechMedical DevicesCalifornia, US

Jeroen(Co-founder and President)Ivan Dimov(Executive Officer, Director)inNathaniel Fernhoff(Executive Officer, Director)in

BoardAlex Kolicich(Director)inJonathan MacQuitty(Director)in

Co-investors8VCDCVC (Data Collective)Felicis VenturesLightspeed Venture PartnersSeraph Group

Partillion generates cell-cell interaction data using Nanovials that co-localize cells in defined microenvironments to measure signaling, activation, binding, and other responses, with live-cell recovery via standard flow cytometry.

AI & Machine LearningBiotechDeep TechLos Angeles, US

Dino Di Carlo(Director)Joe de Rutte(Founder)inEric Moessinger(Director)

BoardPaul Conley(Director)

Co-investorsGENERAL INCEPTIONPaladin Capital GroupVertical Venture Partners

Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer.

AI & Machine LearningBiotechHealthtechSan Francisco, US

Justin Farlow(Co-founder)Colin Farlow(Co-founder)Eric Moessinger(Director)

SiMa.ai designs silicon and software to enable machine learning inference at the edge, deployed in industrial, automotive, and autonomous systems rather than cloud environments.

AI & Machine LearningDeep TechHardwareSemiconductorsSan Jose, US

Krishna Rangasayee(Founder & CEO)in

Co-investorsAmplify PartnersWing

SPARK Microsystems develops ultra-wideband (UWB) wireless connectivity technology for applications including Physical AI, XR, audio, gaming, human interface, and IoT devices.

Deep TechHardwareIoTSemiconductors

Co-investorsSilicon CatalystCycle Capital

BiotechWatertown, US

Omid Farokhzad(Director)inRobert S. Langer, Jr.(Director)Omid C. Farokhzad(Director)inRobert S. Langer(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)in

Co-investorsKendall Capital Partners

Visby offers an FDA-authorized at-home PCR test kit for women's sexual health that detects chlamydia, gonorrhea, and trichomoniasis from a single swab, delivering private results via a mobile app in about 30 minutes with included same-day telehealth for positive results.

ConsumerDigital HealthFemTechHealthtechMedical DevicesTokyo, US

Adam de la Zerda(Founder)in

Co-investors1809 CapitalAmplify PartnersArtiman VenturesG Vision CapitalKhosla VenturesSeraph Group+5 more